The Scientist

» PLoS

Most Recent

image: Another Retraction for Diabetes Researcher

Another Retraction for Diabetes Researcher

By | May 23, 2016

PLOS Biology pulls a 2011 study led by Mário Saad, while his institution investigates additional allegations of research misconduct related to papers published in other journals. 

0 Comments

image: Opinion: Share Data for All Diseases

Opinion: Share Data for All Diseases

By | April 28, 2016

Along with his recent $250 million donation to cancer research, Silicon Valley entrepreneur Sean Parker emphasized the importance of data sharing.

1 Comment

image: Concerns Raised Online Linger

Concerns Raised Online Linger

By | August 25, 2014

Users of post-publication peer review forums like PubPeer often question perceived inaccuracies in scientific papers. Are the journals that published those papers paying attention?

3 Comments

image: Surprise XMRV Retraction

Surprise XMRV Retraction

By | September 21, 2012

The journal PLOS Pathogens abruptly retracts the seminal paper linking XMRV to disease.

2 Comments

image: Disaster-centric Journal Launched

Disaster-centric Journal Launched

By | March 29, 2012

The open-access Public Library of Science has launched a new journal to publish and disseminate scientific information quickly in the wake of disaster.

0 Comments

image: MRSA Found in Antibiotic-free Meat

MRSA Found in Antibiotic-free Meat

By | February 2, 2012

Just because meat is labeled “antibiotic-free” doesn’t mean it’s antibiotic-resistant superbug-free.

0 Comments

image: Gould's bias

Gould's bias

By | June 16, 2011

A new study finds that Stephen J. Gould's criticisms of another scientist's data was misplaced, and the eminent biologist and historian succumbed to data bias himself.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech